Evidence map›Paper›PMID 32266555›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2020

Parental health spillover effects of paediatric rare genetic conditions.

You Wu, Hareth Al-Janabi, Andrew Mallett, Catherine Quinlan, Ingrid E Scheffer, Katherine B Howell, John Christodoulou, Richard J Leventer, Paul J Lockhart, Zornitza Stark and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. A systematic review of economic evaluations forInternational journal of technology assessment in health care · 2023
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Review
  9. Article
  10. Article
  11. Measuring health spillover effects in household members of adolescents and elderly individuals with health issues in China.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  12. Article
  13. Review
  14. The psychometric performance of the EQ-HWB-9 for measuring health and wellbeing in a general population sample from Australia and New Zealand.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  15. Article
  16. Review
  17. The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Article
  18. On spillovers in economic evaluations: definition, mapping review and research agenda.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

You WuCentre for Health Policy, University of Melbourne, Melbourne, VIC, Australia.
Hareth Al-JanabiInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Andrew MallettAustralian Genomics Health Alliance, Melbourne, VIC, Australia.
Catherine QuinlanAustralian Genomics Health Alliance, Melbourne, VIC, Australia.
Ingrid E SchefferAustralian Genomics Health Alliance, Melbourne, VIC, Australia.
Katherine B HowellMurdoch Children's Research Institute, Melbourne, VIC, Australia.
John ChristodoulouAustralian Genomics Health Alliance, Melbourne, VIC, Australia.
Richard J LeventerAustralian Genomics Health Alliance, Melbourne, VIC, Australia.
Paul J LockhartAustralian Genomics Health Alliance, Melbourne, VIC, Australia.
Zornitza StarkAustralian Genomics Health Alliance, Melbourne, VIC, Australia.
Tiffany BoughtwoodAustralian Genomics Health Alliance, Melbourne, VIC, Australia.
Ilias GoranitisCentre for Health Policy, University of Melbourne, Melbourne, VIC, Australia. ilias.goranitis@unimelb.edu.au.

Funding

National Health and Medical Research Council GNT1113531
6 · The paper itself

Abstract

purposeThe complexity and severity of rare genetic conditions pose substantial burden to families. While the importance of spillovers on carers' health in resource allocation decisions is increasingly recognised, there is significant lack of empirical evidence in the context of rare diseases. The objective of this study was to estimate the health spillovers of paediatric rare genetic conditions on parents.

methodsHealth-related quality-of-life (HRQoL) data from children with rare genetic conditions (genetic kidney diseases, mitochondrial diseases, epileptic encephalopathies, brain malformations) and their parents were collected using the CHU9D and SF-12 measures, respectively. We used two approaches to estimate parental health spillovers. To quantify the 'absolute health spillover', we matched our parent cohort to the Australian general population. To quantify the 'relative health spillover', regression models were applied using the cohort data.

resultsParents of affected children had significantly lower HRQoL compared to matched parents in the general public (- 0.06; 95% CIs - 0.08, - 0.04). Multivariable regression demonstrated a positive association between parental and child health. The mean magnitude of HRQoL loss in parents was estimated to be 33% of the HRQoL loss observed in children (95% CIs 21%, 46%).

conclusionPaediatric rare genetic conditions appear to be associated with substantial parental health spillovers. This highlights the importance of including health effects on family members and caregivers into economic evaluation of genomic technologies and personalised medicine. Overlooking spillover effects may undervalue the benefits of diagnosis and management in this context. This study also expands the knowledge of family spillover to the rare disease spectrum.

Indexed as

AdultFemaleHumansMaleParentsQuality of LifeRare DiseasesEconomic evaluationGenomic medicineInformal careQuality of lifeRare disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.